Search Results - "Bardenstein, Leonid M"
-
1
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Published in Nature medicine (01-09-2007)“…Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathological features of disrupted neuronal excitability and plasticity within…”
Get full text
Journal Article -
2
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
Published in European child & adolescent psychiatry (2010)“…The objective of the study was to compare the efficacy and tolerability of once-daily atomoxetine (≤1.8 mg/(kg day) with those of placebo in children and…”
Get full text
Journal Article -
3
Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Published in Nature medicine (01-10-2007)Get full text
Journal Article -
4
Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Published in Nature medicine (01-10-2007)Get full text
Journal Article